These data showed that rare loss of function variations of UNC13D are observed in ALPS patients with a higher frequency (7%) than in the healthy control (0%), DALD (0%), and MS (0%) groups. This evidence concerns the gene UNC13D and autoimmune lymphoproliferative syndrome.